VitaNova Life Sciences (VNOV) Long-Term Deferred Tax (2018 - 2026)

VitaNova Life Sciences has reported Long-Term Deferred Tax for 9 years, with the latest figure at $98161.0 in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Deferred Tax rose 8.09% year-over-year to $98161.0; the trailing twelve-month figure through Jan 2026 stood at $98161.0 (up 8.09% YoY), and the FY2025 full-year result was $102611.0, up 118.47% from the prior year.
• Long-Term Deferred Tax for Q1 2026 stood at $98161.0, down from $147929.0 in the prior quarter.
• The five-year high for Long-Term Deferred Tax was $147929.0 in Q4 2025, with the low at $1813.0 in Q4 2022.
• Historically, Long-Term Deferred Tax has averaged $61472.1 across 5 years, with a median of $56557.5 in 2024.
• Annual changes were most pronounced in 2022 — Long-Term Deferred Tax tumbled 58.36% — and 2023, when it soared 1717.54%.
• VitaNova Life Sciences' Long-Term Deferred Tax stood at $1813.0 in 2022, then soared by 1717.54% to $32952.0 in 2023, then soared by 139.4% to $78887.0 in 2024, then surged by 87.52% to $147929.0 in 2025, then slumped by 33.64% to $98161.0 in 2026.
• The last three Long-Term Deferred Tax figures came in at $98161.0 (Q1 2026), $147929.0 (Q4 2025), and $120008.0 (Q3 2025), per Business Quant data.